HLTH355 Lecture Notes - Lecture 40: Bioequivalence, Prescription Drug, The New York Times

• School: University of Waterloo
• Department: Health Studies
• Course: HLTH355
• Professor: Sharon Kirkpatrick

Document Summary

Article: how alcohol industry organizations mislead the public about alcohol and cancer. Mark petticrew phd, professor of public health evaluation, nason maani hessari phd, research. Fellow, c cile knai phd, associate professor of public health policy, elisabete weiderpass md, How the alcohol industry organisations under review misrepresent the evidence on alcohol and cancer: denial/omission: denying, or disputing any link with cancer, or selective omission of the relationship. The approach includes: denying that any relationship exists, or claiming inaccurately that there is no risk for light or (cid:858)(cid:373)oderate(cid:859) dri(cid:374)ki(cid:374)g, selective omission: avoiding mention of cancer in general, or of specific cancers. Article: strategies that delay market entry of generic drugs. Vokinger kn, kesselheim as, avorn j, sarpatwari a. Abstract: increasing prescription drug expenditures in the united states are primarily driven by high brand-name drug prices. Although generic competition helps lower drug prices, manufacturers of brand-name drugs often work to delay the availability of generic versions of their products.